biontech us

biontech us : Related News

• Jun. 30, 2022 - Pfizer and BioNTech Announce New Agreement with US Government to Provide Additional Doses of COVID-19 Vaccine  PfizerPfizer and BioNTech to Get $3.2 Billion From US in Covid Vaccine Deal  BloombergPfizer, BioNTech enter $3.2bn deal with US government for Covid-19 shots  Pharmaceutical TechnologyRecon: US signs $3.2B deal for Pfizer-BioNTech vaccines; Novartis said to lean toward spinoff of generics unit  Regulatory FocusU.S. to pay $3.2 billion to Pfizer, BioNTech for more COVID-19 vaccines for fall  MarketWatchView Full Coverage on Google Newswww.pfizer.comPfizer and BioNTech Announce New Agreement with US Government to Provide Additional Doses of COVI...
• Jul. 6, 2022 - Germany's CureVac Files Suit Against Vaccine Rival BioNTech  U.S. News & World ReportCureVac sues BioNTech for infringement on its mRNA technology  FiercePharmaGermany's BioNTech sued by rival over Covid jab formula  Expatica BelguimCureVac sues rival COVID-19 vaccine maker BioNTech for patent infringement  BioPharma DiveCureVac sues BioNTech over mRNA patents  Financial TimesView Full Coverage on Google Newswww.usnews.comGermany's CureVac Files Suit Against Vaccine Rival BioNTech - U.S. News & World Report
• Jun. 25, 2022 - Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron  Pfizerwww.pfizer.comPfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune ...
• Jun. 17, 2022 - Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age | FDA  FDA.govwww.fda.govCoronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for C...
• Jun. 9, 2022 - BioNTech to Soon Start MRNA Vaccine Factory Construction in Rwanda  U.S News & World Report Moneymoney.usnews.comBioNTech to Soon Start MRNA Vaccine Factory Construction in Rwanda - U.S News & World Report Money
• Jul. 1, 2022 - Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022 | MMWR  Centers for Disease Control and Prevention (.gov)www.cdc.govInterim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna an...
• Jun. 30, 2022 - Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide 105M Doses of COVID-19 Vaccine  Benzingawww.benzinga.comPfizer and BioNTech Announce New Agreement with U.S. Government to Provide 105M Doses of COVID-19...
• Jul. 6, 2022 - Pfizer CEO's call brought Biohaven back onto the M&A track  FiercePharmawww.fiercepharma.comPfizer CEO's call brought Biohaven back onto the M&A track - FiercePharma
• Jul. 1, 2022 - Why BioNTech Stock Advanced Today  The Motley Foolwww.fool.comWhy BioNTech Stock Advanced Today - The Motley Fool
• Jul. 6, 2022 - FDA will review Amylyx's ALS drug with a second expert panel  FiercePharmawww.fiercepharma.comFDA will review Amylyx's ALS drug with a second expert panel - FiercePharma
• Jul. 6, 2022 - Seagen touts new Tukysa colorectal cancer data, setting up FDA filing and a potential $500M opportunity  FiercePharmawww.fiercepharma.comSeagen touts new Tukysa colorectal cancer data, setting up FDA filing and a potential $500M oppor...
• Jun. 30, 2022 - U.S. FDA advisers recommend change to COVID vaccine composition for fall  Reuters.comwww.reuters.comU.S. FDA advisers recommend change to COVID vaccine composition for fall - Reuters.com
• Jun. 30, 2022 - Sanofi cuts insulin price for uninsured in US from $99 to $35  FiercePharmawww.fiercepharma.comSanofi cuts insulin price for uninsured in US from $99 to $35 - FiercePharma
• Jul. 6, 2022 - GSK's Haleon will launch with more than £10B in debt: report  FiercePharmawww.fiercepharma.comGSK's Haleon will launch with more than £10B in debt: report - FiercePharma
• Jul. 6, 2022 - EMEA Morning Briefing: Shares to Bounce Back on U.S. Rebound; Oil Steadies  Morningstarwww.morningstar.comEMEA Morning Briefing: Shares to Bounce Back on U.S. Rebound; Oil Steadies - Morningstar
• Jun. 30, 2022 - For $275M, Lilly to provide more COVID antibody doses to US  FiercePharmawww.fiercepharma.comFor $275M, Lilly to provide more COVID antibody doses to US - FiercePharma
• Jul. 6, 2022 - Helping countries vaccinate children against COVID-19 - US Embassy & Consulates in Italy  US Embassy Romeit.usembassy.govHelping countries vaccinate children against COVID-19 - US Embassy & Consulates in Italy - US Emb...
• Jul. 6, 2022 - Health Care Sector Update for 07/05/2022: TYME, DYN, CVAC, BNTX, XLV, IBB  Nasdaqwww.nasdaq.comHealth Care Sector Update for 07/05/2022: TYME, DYN, CVAC, BNTX, XLV, IBB - Nasdaq
• Jun. 28, 2022 - Covid Updates: C.D.C. Recommends 2 Covid Vaccines for Very Young Children  The New York Timeswww.nytimes.comCovid Updates: C.D.C. Recommends 2 Covid Vaccines for Very Young Children - The New York Times
• Jul. 6, 2022 - The Zacks Analyst Blog Highlights Abbott, T-Mobile US, Intuit, Analog Devices and The Progressive  Nasdaqwww.nasdaq.comThe Zacks Analyst Blog Highlights Abbott, T-Mobile US, Intuit, Analog Devices and The Progressive...